ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.96
+0.46 (8.36%)
At close: Dec 5, 2025, 4:00 PM EST
5.95
-0.01 (-0.17%)
After-hours: Dec 5, 2025, 7:38 PM EST
ENDRA Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -8.01 | -11.51 | -10.06 | -13.18 | -11.23 | -11.73 | |
| Depreciation & Amortization | 0.16 | 0.21 | 0.28 | 0.23 | 0.22 | 0.17 | |
| Other Amortization | - | - | - | - | - | 0.23 | |
| Asset Writedown & Restructuring Costs | - | 0.01 | 0.02 | 0 | 0.01 | - | |
| Stock-Based Compensation | 0.42 | 0.57 | 1 | 1.2 | 1.44 | 2.1 | |
| Other Operating Activities | 2.07 | 3.19 | 0.14 | - | -0.31 | - | |
| Change in Inventory | 0.33 | 0.24 | -0.12 | -1.36 | -0.69 | -0.48 | |
| Change in Accounts Payable | 0.04 | -0.2 | -0.82 | 0.11 | 0.49 | -0.83 | |
| Change in Other Net Operating Assets | -0.1 | 0.1 | 0.02 | 0.22 | -1.06 | -0.21 | |
| Operating Cash Flow | -5.09 | -7.4 | -9.55 | -12.77 | -11.12 | -10.75 | |
| Capital Expenditures | -0.02 | -0.02 | -0.03 | -0.2 | -0.05 | -0.08 | |
| Sale of Property, Plant & Equipment | - | 0 | 0.01 | - | - | - | |
| Investing Cash Flow | -0.02 | -0.01 | -0.02 | -0.2 | -0.05 | -0.08 | |
| Long-Term Debt Issued | - | - | - | - | - | 0.34 | |
| Total Debt Issued | - | - | - | - | - | 0.34 | |
| Long-Term Debt Repaid | - | -0.03 | - | - | - | - | |
| Total Debt Repaid | - | -0.03 | - | - | - | - | |
| Net Debt Issued (Repaid) | - | -0.03 | - | - | - | 0.34 | |
| Issuance of Common Stock | - | 1.15 | 6.48 | 8.4 | 13.4 | 11.54 | |
| Other Financing Activities | 5.37 | 6.69 | 1.03 | - | - | - | |
| Financing Cash Flow | 1.15 | 7.81 | 7.52 | 8.4 | 13.4 | 11.88 | |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | |
| Net Cash Flow | -3.95 | 0.4 | -2.06 | -4.57 | 2.23 | 1.05 | |
| Free Cash Flow | -5.1 | -7.42 | -9.58 | -12.97 | -11.17 | -10.82 | |
| Free Cash Flow Per Share | -7.92 | -36.70 | - | - | - | - | |
| Cash Interest Paid | 0.05 | 0.03 | 0.04 | 0.06 | 0.06 | 0 | |
| Levered Free Cash Flow | -4.49 | -6.22 | -5.86 | -4.78 | -6.75 | -6.39 | |
| Unlevered Free Cash Flow | -4.49 | -6.22 | -5.86 | -4.78 | -6.75 | -6.47 | |
| Change in Working Capital | 0.27 | 0.13 | -0.92 | -1.03 | -1.26 | -1.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.